semaglutide for hfpef In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress Potential action mechanisms of semaglutide

The extended-release (ER) formulation encapsulates exenatide within biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres, which form a polymeric matrix that allows sustained drug release following SC administration [13, 14, 58]

It received GRAS (Generally Recognized as Safe) status for use as a food ingredient, which is a separate regulatory category

Incretin analogue treatment results in weight loss with a substantial reduction in cardiovascular risk factors

[PubMed] 133.Webb J, Dubose J

Many patients consider this an investment in their healthcomparable to what theyd spend on fad diets, gym memberships, or supplements that dont deliver lasting results

Marco, J